In January 2012, ANMAT (the agency responsible for the national regulation of drugs, foods and medical technology in Argentina) approved the product for treatment of hepatitis C, multiple sclerosis and cancers in patients whose treatment with recombinant alpha interferon
fails or who become intolerant to treatment with recombinant alpha interferon
as a result of the appearance of neutralizing antibodies.
Cummins's work with natural alpha interferon
at low doses, and W.
Belerofon(R) has a superior pharmacological profile, with a half-life in primates equivalent to marketed pegylated alpha interferon
In addition, Schering-Plough has agreed to commence paying royalties to Biogen on United States sales of Schering-Plough's alpha interferon
products, based on a 1998 agreement between the two companies.
Although some physicians recommend adding antidepressants to alpha interferon
as a prophylaxis for depression, this may tend to increase the risk that patients will experience mania or psychosis, said Dr.
The Dutch study treated 28 KS patients with high dosages of alpha interferon
every day for eight weeks.
Well, it turns out that beta and alpha interferon
both block many of the effects of gamma interferon.
autoimmune thrombocytopenia, idiopathic thrombocytopenic purpura, psoriasis, rheumatoid arthritis) have been reported in patients receiving alpha interferon
therapies, including INFERGEN.
OTC BB: "VGNI") today announced results from a sponsored in vitro study conducted at Umea University in Sweden, which found that Multiferon(R) (multi- subtype, human alpha interferon
) suppressed development of resistant human melanoma clones to a far greater degree than recombinant alpha interferon
On January 19, 2001, the FDA granted marketing approval to PEG-INTRON as once-weekly monotherapy for the treatment of chronic hepatitis C in patients not previously treated with alpha interferon
who have compensated liver disease and are at least 18 years of age.
San Francisco, CA; 415-266-1000)(1997 revenue - $902 million) that settle a 1996 lawsuit Biogen filed against Roche and Genentech related to a disputed alpha interferon
AIDS patients with Kaposi's sarcoma -- a normally rare cancer that strikes many people with AIDS--can benefit from a double-whammy treatment consisting of zidovudine and alpha interferon
, a naturlly occurring protein.